Filing summary
Company: Intelligent Bio Solutions Inc. (Nasdaq: INBS). Filing: Form 8-K reporting an event dated October 12, 2026; signed October 13, 2026. This is not a periodic financial report.
Business and governance
On October 12, 2026, the board adopted the Company’s Second Amended and Restated Bylaws. Section 2.6 clarifies that, for stockholder-meeting matters other than director elections, approval requires a majority of votes cast. Broker non-votes and abstentions are excluded and do not affect the outcome. The complete bylaws are identified as Exhibit 3.1.
Financial performance and outlook
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial results, and no comparative-period data or guidance. It does not provide management commentary or financial risk and contingency disclosures.
Investor presentation
The Company said it made an investor presentation available on October 13, 2026, concerning its business and operations. The filing points investors to the Investors section of the Company’s website and lists the presentation as Exhibit 99.1. The presentation’s contents are not included in the provided filing text. Item 7.01 information is furnished, not deemed filed, except as specified in the filing.
Key facts to verify
- Review Exhibit 3.1 for the full bylaw amendments and their precise application.
- Review Exhibit 99.1 or the Company’s investor website for the presentation’s business updates, outlook, and any financial information.
- Confirm the effective date and voting treatment in the complete bylaws.